The private-equity firm has agreed to sell its entire stake in India-listed J.B. Chemicals & Pharmaceuticals to Torrent ...

The private equity industry has experienced a notable shift with a growing wave of high-profile public listings worldwide.

Private equity giant KKR exits JB Chemicals with a ₹11,900 crore deal, reinforcing its track record in India's healthcare ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $136.8, a high ...

MUMBAI] Torrent Pharmaceuticals agreed to take a controlling stake in JB Chemicals & Pharmaceuticals from private equity firm ...

KKR & Co. Inc. (NYSE:KKR) one of the best stocks in a Growth Stock Portfolio. Recently, on June 24, 2025, Assura Group, based ...

Merger between Torrent and JB Pharma through a scheme of arrangement. As per the approval given by the Board of Directors of both companies, upon merger of JB Pharma with Torrent, every shareholder ...

Explore the escalating trend of private equity's investment in wealth management firms and its implications on the financial ...

China’s sovereign wealth fund has pulled its planned sale of $1 billion in U.S. fund stakes tied to some of the biggest names ...

The Assura takeover saga is fast becoming a story worthy of a daytime soap opera. A tie-up between Assura and Primary Health ...

Meta Platforms is in advanced talks to raise $29 billion from private equity firms as it invests further in building data centers for artificial intelligence, the Financial Times reported . Apollo ...

A takeover battle for one of London’s healthcare REITs took a new turn after the board switched its recommendation from an ...